Spruce Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Spruce Biosciences

15/05/2023 14:25

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 40 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 36 cents per share.
    * Revenue was $1.96 million​; analysts expected $500.00
thousand. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 34.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had risen by 0.9% this
quarter and
gained 103.2% so far this year.
    * The company reported a quarterly loss of $12.76 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:25 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.36          -0.40          Missed
 Dec. 31 2022      -0.53          -0.47          Beat
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.52          -0.51          Beat